Controlling a computer with your mind was once pure science fiction, but it's now plausible thanks to brain-computer ...

The San Diego biotech made an unsolicited bid to buy Evotec for 2 billion euros. Elsewhere, Bluebird recorded its first ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

View the full release here: "We are honored to be recognized with the Prix Galien Award for Best Digital Health Solution," ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

A study has found that aficamten is associated with improvements across a range of clinical outcomes in patients with obstructive hypertrophic cardiomyopathy.

Rolling Submission of NDA for Aficamten Completed and Submitted to FDA in Q3 COMET-HF, Confirmatory Phase 3 Clinical Trial of ...

Researchers have found a new treatment protocol that may help some people with this deadly cancer to survive longer. News 8’s Brittany Noble has details in Thursday’s Health Spotlight.

Lexicon Pharmaceuticals (NASDAQ:LXRX) lost ~39% in the morning hours on Friday following a trading halt in the previous session as an FDA advisory committee declined to endorse its diabetes therapy ...

People with hypertrophic cardiomyopathy (HCM) have a greater risk of becoming severely ill from COVID-19. Furthermore, the virus has been found to significantly damage the heart muscle, causing ...

The Supreme Court on Friday (October 25, 2024) agreed to examine a plea to scrap the levy of ‘VIP entry charges’ and according of “preferential, selective and special treatment” to a ...

According to a news release, this event offers a convenient, drive-thru, drop-off format, allowing participants to discard their medications without even having to leave their vehicles.